CAS Number: 915087-33-1

Stage: Pipeline

Enzalutamide is a potent androgen receptor inhibitor used in the treatment of metastatic and non-metastatic castration-resistant prostate cancer (CRPC). It blocks multiple steps in the androgen receptor signaling pathway, improving overall survival. Enzalutamide is a cornerstone of hormonal therapy in advanced prostate cancer. Explore Royal Pharma as your potential partner for Enzalutamide API.